FDA grants Fast Track designation to VS-7375, an oral investigational KRAS G12D inhibitor, for locally advanced or metastatic ...
HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...
ImmunityBio (NasdaqGS:IBRX) presented new clinical data on ANKTIVA in advanced non small cell lung cancer and BCG unresponsive non muscle invasive bladder cancer at the 2026 ASCO Annual Meeting. The ...
It's natural to feel afraid after a lung cancer diagnosis. But there's also real reason for hope, as treatment for lung cancer has improved dramatically in the last decade. (DigitalVision/Getty Images ...
The two main categories for lung cancer are small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Large cell lung cancer (LCLC) is a type of NSCLC. While the conditions share some ...
First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with ...
SurvivorNet on MSN
A new type of immunotherapy drug showed striking results in hard-to-treat lung cancer, but more data is needed for US patients
A large clinical trial in China (HARMONi-6) found that a new immunotherapy drug, ivonescimab, may help patients with advanced ...
The U.S. Food and Drug Administration on Friday approved an Amgen Inc drug for non-small cell lung cancer with a specific mutation in a gene known as KRAS in patients whose disease has worsened after ...
CHICOPEE, Mass. (WWLP) – World Lung Cancer Day has been observed every year on August 1 since 2012 to raise awareness about the risk of the disease. Cooler start to August in western Massachusetts The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results